» Articles » PMID: 18435577

On the Interpretation of Rat Carcinogenicity Studies for Human PTH(1-34) and Human PTH(1-84)

Overview
Date 2008 Apr 26
PMID 18435577
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Therapeutic Opportunities of Targeting Allosteric Binding Sites on the Calcium-Sensing Receptor.

Diao J, DeBono A, Josephs T, Bourke J, Capuano B, Gregory K ACS Pharmacol Transl Sci. 2021; 4(2):666-679.

PMID: 33860192 PMC: 8033781. DOI: 10.1021/acsptsci.1c00046.


Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

Winer K, Kelly A, Johns A, Zhang B, Dowdy K, Kim L J Pediatr. 2018; 203:391-399.e1.

PMID: 30470382 PMC: 6298875. DOI: 10.1016/j.jpeds.2018.08.010.


Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.

Takeda S, Sakai S, Tanaka K, Tomizawa H, Serizawa K, Yogo K Calcif Tissue Int. 2017; 101(1):65-74.

PMID: 28246925 PMC: 5486915. DOI: 10.1007/s00223-017-0255-6.


Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.

Ho P, Goradia A, Russell M, Chalk A, Milley K, Baker E Oncogene. 2014; 34(22):2922-33.

PMID: 25043296 DOI: 10.1038/onc.2014.217.


[Influence of parathyroid hormone and estrogen on alveolar bone metabolism of castrated female rats].

Sun Z, Lin Z, Bai G, Di J, Jiang L Hua Xi Kou Qiang Yi Xue Za Zhi. 2014; 32(2):134-7.

PMID: 24881206 PMC: 7030809.